Pocklington: ‘We Will Vigorously Defend Ourselves and our Nova Oculus Device from Outrageous Allegations’

Share Article

Nova Oculus founder stands by innovative medical device

Nova Oculus Partners, LLC today issued the following statement from its founder Peter Pocklington:

Egregious allegations against me, two of my associates, and our company, Nova Oculus Partners, LLC, have surfaced in recent days, most recently in the Desert Sun. These claims by the U.S. Securities and Exchange Commission, are outrageous, and we intend to vigorously defend our company, its reputation and the medical device our talented and innovative team has developed to treat the dry form of Age-Related Macular Degeneration.

Make no mistake: our Nova Oculus device will revolutionize the treatment protocols for dry AMD and offer hope to millions of Americans who would otherwise go blind. Dry AMD is an affliction without a cure, yet our microcurrent electro-therapy technology successfully mitigates its symptoms. That’s not just my opinion. It is shared by the engineering and medical professionals that are part of the Nova Oculus family, including some of the leading optometric professionals who serve on our medical advisory board. Successfully bringing the Nova Oculus device to market is our mission, and we will not shrink from that responsibility.

Knowing the Nova Oculus device is a valid treatment protocol for treating dry AMD gives us the strength to fight these scurrilous allegations. I am confident the truth will emerge to exonerate me and my associates.

Peter Pocklington
Founder, Nova Oculus

Share article on social media or email:

View article via:

Pdf Print

Contact Author

D. Hernandez

John McNeil